IL6 and sarcoidosis: With the exception of IL-8, each biomarker in the sarcoidosis panel (eNAMPT, IL-6, ANG-2 IL-1RA, and HBEGF) accurately discriminated between healthy controls and sarcoidosis subjects, with an optimal threshold > 74%.